These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 4606887

  • 1. Parkinson's disease and levodopa. A five-year follow-up and review.
    Markham CH, Treciokas LJ, Diamond SG.
    West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887
    [No Abstract] [Full Text] [Related]

  • 2. [Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients].
    Sigwald J, Chomette G, Raymondeaud C.
    Sem Hop; 1972 Feb 20; 48(9):609-24. PubMed ID: 4339429
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A review of some aspects of the pharmacology of levodopa.
    Morris JG.
    Clin Exp Neurol; 1978 Feb 20; 15():24-50. PubMed ID: 386308
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of parkinsonism with levodopa.
    Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM.
    Arch Neurol; 1969 Oct 20; 21(4):343-54. PubMed ID: 5820999
    [No Abstract] [Full Text] [Related]

  • 10. Parkinson's disease: progression and mortality in the L-DOPA era.
    Di Rocco A, Molinari SP, Kollmeier B, Yahr MD.
    Adv Neurol; 1996 Oct 20; 69():3-11. PubMed ID: 8615142
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. L-dopa in postencephalitic parkinsonism.
    Calne DB, Stern GM, Laurence DR, Sharkey J, Armitage P.
    Lancet; 1969 Apr 12; 1(7598):744-6. PubMed ID: 4180215
    [No Abstract] [Full Text] [Related]

  • 13. Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
    Markham C, Diamond SG, Treciokas LJ.
    Arch Neurol; 1974 Aug 12; 31(2):128-33. PubMed ID: 4834974
    [No Abstract] [Full Text] [Related]

  • 14. L-dopa in idiopathic parkinsonism.
    Calne DB, Stern GM, Spiers AS, Laurence DR.
    Lancet; 1969 Nov 08; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract] [Full Text] [Related]

  • 15. Medical treatment of Parkinson disease.
    Stacy M.
    Neurol Clin; 2009 Aug 08; 27(3):605-31, v. PubMed ID: 19555824
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.
    Barbeau A.
    Can Med Assoc J; 1975 Jun 21; 112(12):1379-80. PubMed ID: 1139474
    [No Abstract] [Full Text] [Related]

  • 18. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F, Fornai F, Blandini F.
    Funct Neurol; 2000 Jun 21; 15(4):269-76. PubMed ID: 11213530
    [No Abstract] [Full Text] [Related]

  • 19. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD.
    Brain; 2009 Feb 21; 132(Pt 2):309-18. PubMed ID: 19050033
    [Abstract] [Full Text] [Related]

  • 20. Sustained levodopa therapy in parkinsonism.
    Hunter KR, Shaw KM, Laurence DR, Stern GM.
    Lancet; 1973 Oct 27; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.